ROBO Global Healthcare Technology and Innovation ETFHTEC
Type
ETF
Peer group
US equity: Healthcare
Net assets
$53.3M
Expense ratio
0.68%
1-year return
+40.5%
3 years, a year
+16.4%
5 years, a year
-2.5%
12-month yield
0.78%
Holdings
62
What it aims to do.
The ROBO Global Healthcare Technology and Innovation ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index (the Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| AXGN AxoGen, Inc. | 3.16% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 2.56% |
| TWST Twist Bioscience Corp | 2.34% |
| GKOS Glaukos Corporation | 2.23% |
| NTRA Natera, Inc. | 2.17% |
| TEM Tempus Ai, Inc. | 2.13% |
| NVCR Novocure Limited | 2.04% |
| ALNY Alnylam Pharmaceuticals, Inc. | 2.01% |
| GH Guardant Health, Inc. | 1.99% |
| TMO Thermo Fisher Scientific Incorporated | 1.99% |
More on HTEC.
- HTEC overview
- HTEC holdings
- HTEC risk
- HTEC costs
- HTEC money in and out
- HTEC share classes
- Compare HTEC with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.